PA
Padmakshi Agarwal
About Padmakshi Agarwal
Data last updated:
Padmakshi Agarwal has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Raspa Pharma Private Limited and Raspa Innovation Lab Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Raspa Pharma Private Limited at ₹78,208 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Aug 2020 | 2020 | ₹78,208 (FY 2024) | Active | |
| Director | 05 Feb 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Padmakshi Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Padmakshi Agarwal
Padmakshi Agarwal has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Raspa Pharma Private Limited and Raspa Innovation Lab Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Raspa Pharma Private Limited at ₹78,208 (FY 2024).
Padmakshi Agarwal is associated with 2 companies as Director, including Raspa Pharma Private Limited (₹78,208), Raspa Innovation Lab Private Limited.
Padmakshi Agarwal has expertise in General Business.
Padmakshi Agarwal has 6 years in corporate governance.
By reported revenue, the largest current company of Padmakshi Agarwal is Raspa Pharma Private Limited, with revenue of ₹78,208 (FY 2024).
Padmakshi Agarwal currently holds positions at 2 companies: Raspa Pharma Private Limited (₹78,208), Raspa Innovation Lab Private Limited.